Heramed Ltd Market Cap ($29.16 Million)
Market Cap & Net Worth: Heramed Ltd (HMD)
Heramed Ltd market cap. Heramed Ltd (AU:HMD) has a market capitalization of $29.16 Million (AU$41.21 Million) as of November 7, 2026. Listed on the AU stock exchange, this Australia-based company holds position #23651 globally and #898 in its home market, demonstrating a -5.13% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Heramed Ltd's stock price AU$0.04 by its total outstanding shares 1113653427 (1.11 Billion). Also see HMD cash flow metrics for how efficiently the company converts equity into cash flow.
Heramed Ltd Market Cap History (2018–2026)
Heramed Ltd market cap history from 2018 to 2026. Data shows change from $126.08 Million to $29.16 Million (-18.14% CAGR). Check HMD stock price and chart for real-time trading data and today's change.
Heramed Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Heramed Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Heramed Ltd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
69.89x
Heramed Ltd's market cap is 69.89 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $126.08 Million | $59.67K | -$2.91 Million | 2112.79x | N/A |
| 2019 | $126.08 Million | $147.14K | -$3.17 Million | 856.84x | N/A |
| 2020 | $86.68 Million | $39.52K | -$3.36 Million | 2193.49x | N/A |
| 2021 | $189.12 Million | $83.68K | -$5.71 Million | 2259.96x | N/A |
| 2022 | $98.50 Million | $215.81K | -$4.88 Million | 456.41x | N/A |
| 2023 | $18.91 Million | $413.19K | -$4.50 Million | 45.77x | N/A |
| 2024 | $15.76 Million | $225.49K | -$3.40 Million | 69.89x | N/A |
Competitor Companies of HMD by Market Capitalization
Companies near Heramed Ltd in the global market cap rankings as of November 7, 2026. Also see HMD current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Heramed Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #106 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #181 globally with a market cap of $128.53 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #106 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $113.60 |
| #181 | Stryker Corporation | NYSE:SYK | $128.53 Billion | $335.08 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $104.84 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Heramed Ltd (2018–2026)
Market capitalization of Heramed Ltd from 2018 to today. Between 2018 and today, Heramed Ltd's market cap moved from $126.08 Million to $ 29.16 Million, with a yearly change of -18.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$29.16 Million | +2.78% |
| 2025 | AU$28.37 Million | +80.00% |
| 2024 | AU$15.76 Million | -16.67% |
| 2023 | AU$18.91 Million | -80.80% |
| 2022 | AU$98.50 Million | -47.92% |
| 2021 | AU$189.12 Million | +118.18% |
| 2020 | AU$86.68 Million | -31.25% |
| 2019 | AU$126.08 Million | 0.00% |
| 2018 | AU$126.08 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of Heramed Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $29.16 Million USD |
| MoneyControl | $29.16 Million USD |
| MarketWatch | $29.16 Million USD |
| marketcap.company | $29.16 Million USD |
| Reuters | $29.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Heramed Ltd
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the … Read more